2023-06-01 2024-03-31 false No description of principal activity Capium Accounts Production 1.1 11975057 2023-06-01 2024-03-31 11975057 bus:FullAccounts 2023-06-01 2024-03-31 11975057 bus:FRS102 2023-06-01 2024-03-31 11975057 bus:AuditExemptWithAccountantsReport 2023-06-01 2024-03-31 11975057 bus:SmallCompaniesRegimeForAccounts 2023-06-01 2024-03-31 11975057 bus:PrivateLimitedCompanyLtd 2023-06-01 2024-03-31 11975057 2023-06-01 2024-03-31 11975057 2024-03-31 11975057 bus:RegisteredOffice 2023-06-01 2024-03-31 11975057 core:WithinOneYear 2024-03-31 11975057 core:AfterOneYear 2024-03-31 11975057 1 2023-06-01 2024-03-31 11975057 bus:Director1 2023-06-01 2024-03-31 11975057 bus:Director1 2024-03-31 11975057 bus:Director1 2022-06-01 2023-05-31 11975057 2022-06-01 11975057 bus:LeadAgentIfApplicable 2023-06-01 2024-03-31 11975057 2022-06-01 2023-05-31 11975057 2023-05-31 11975057 core:WithinOneYear 2023-05-31 11975057 core:AfterOneYear 2023-05-31 11975057 bus:EntityAccountantsOrAuditors 2022-06-01 2023-05-31 11975057 core:PlantMachinery 2023-06-01 2024-03-31 11975057 core:PlantMachinery 2024-03-31 11975057 core:PlantMachinery 2023-05-31 11975057 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-03-31 11975057 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-05-31 11975057 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 11975057 core:CostValuation core:Non-currentFinancialInstruments 2023-05-31 11975057 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-03-31 11975057 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-03-31 11975057 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-03-31 11975057 core:Non-currentFinancialInstruments 2024-03-31 11975057 core:Non-currentFinancialInstruments 2023-05-31 11975057 core:ShareCapital 2024-03-31 11975057 core:ShareCapital 2023-05-31 11975057 core:RetainedEarningsAccumulatedLosses 2024-03-31 11975057 core:RetainedEarningsAccumulatedLosses 2023-05-31 11975057 core:ShareCapitalOrdinaryShares 2023-06-01 11975057 core:ShareCapitalOrdinaryShares 2022-06-01 11975057 core:ShareCapitalOrdinaryShares 2023-06-01 2024-03-31 11975057 core:ShareCapitalOrdinaryShares 2022-06-01 2023-05-31 11975057 core:ShareCapitalOrdinaryShares 2024-03-31 11975057 core:ShareCapitalOrdinaryShares 2023-05-31 11975057 core:RetainedEarningsAccumulatedLosses 2023-06-01 11975057 core:RetainedEarningsAccumulatedLosses 2022-06-01 11975057 core:RetainedEarningsAccumulatedLosses 2023-06-01 2024-03-31 11975057 core:RetainedEarningsAccumulatedLosses 2022-06-01 2023-05-31 11975057 core:RetainedEarningsAccumulatedLosses 2024-03-31 11975057 core:RetainedEarningsAccumulatedLosses 2023-05-31 11975057 dpl:Item1 2023-06-01 11975057 dpl:Item1 2024-03-31 11975057 dpl:Item1 2022-06-01 11975057 dpl:Item1 2023-05-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 11975057
England and Wales

 

 

 

HAROON AND SONS MEDICAL SERVICES LIMITED


Unaudited Financial Statements
 


Period of accounts

Start date: 01 June 2023

End date: 31 March 2024
Director Ishrat Muhammad YOUSUF
Registered Number 11975057
Registered Office 635 CHATSWORTH ROAD
CHESTERFIELD
S40 3NT
Accountants Tax Whizz
Greencoat House, First Floor
259 Stratford Road
Birmingham
B11 1QS
1
Director's report and financial statements
The director presents his/her/their annual report and the financial statements for the year ended 31 March 2024.
Director
The director who served the company throughout the period was as follows:
Ishrat Muhammad YOUSUF
Statement of director's responsibilities
The director is responsible for preparing the directors' report and the financial statements in accordance with applicable law and regulations and in accordance with United Kingdom Generally Accepted Accounting Practice.
Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the profit or loss of the company for that period.
In preparing these financial statements, the director is required to :
  • select suitable accounting policies and then apply them consistently
  • make judgements and accounting estimates that are reasonable and prudent
  • state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements and
  • prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. The director is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The director is responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom, governing the preparation and dissemination of financial statements, may differ from legislation in other jurisdictions

On behalf of the board.


----------------------------------
Ishrat Muhammad YOUSUF
Director

Date approved: 31 March 2025
2
Accountant’s report
You consider that the company is exempt from an audit for the year ended 31 March 2024 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year.
In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us.
We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts.
Tax Whizz
31 March 2024



....................................................

Tax Whizz

Greencoat House, First Floor
259 Stratford Road
Birmingham
B11 1QS
31 March 2025
3
 
 
Notes
 
2024
£
  2023
£
Turnover 89,600    109,600 
Cost of sales (1,489)   (1,425)
Gross profit 88,111    108,175 
Administrative expenses (33,542)   (34,843)
Operating profit 54,569    73,332 
Profit/(Loss) on ordinary activities before taxation 54,569    73,332 
Tax on profit on ordinary activities (11,455)   (14,344)
Profit/(Loss) for the financial period 43,114    58,988 
 
4
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Tangible fixed assets 3 1,298    1,781 
Investments 4 12,150    12,150 
13,448    13,931 
Current assets      
Cash at bank and in hand 15,085    (2,588)
Creditors: amount falling due within one year 5 (11,574)   (14,541)
Net current assets 3,511    (17,129)
 
Total assets less current liabilities 16,959    (3,198)
Creditors: amount falling due after more than one year 6 (60)   (34)
Net assets 16,899    (3,232)
 

Capital and reserves
     
Called up share capital 2    2 
Profit and loss account 16,897    (3,234)
Shareholders' funds 16,899    (3,232)
 


For the period ended 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 31 March 2025 and were signed by:


-------------------------------
Ishrat Muhammad YOUSUF
Director
5
  Equity share capital   Retained Earnings   Total
£ £ £
At 01 June 2022 2  10,578  10,580 
Profit for the period 58,988  58,988 
Total comprehensive income for the period 58,988  58,988 
Dividends (72,800) (72,800)
Total investments by and distributions to owners (72,800) (72,800)
At 31 May 2023 2  (3,234) (3,232)
At 01 June 2023 2  483  485 
Profit for the period 43,114  43,114 
Total comprehensive income for the period 43,114  43,114 
Dividends (26,700) (26,700)
Total investments by and distributions to owners (26,700) (26,700)
At 31 March 2024 2  16,897  16,899 
6
General Information
HAROON AND SONS MEDICAL SERVICES LIMITED is a private company, limited by shares, registered in England and Wales, registration number 11975057, registration address 635 CHATSWORTH ROAD, CHESTERFIELD, S40 3NT.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
2.

Average number of employees

Average number of employees during the period was 1 (2023 : 1).
3.

Tangible fixed assets

Cost or valuation Plant and Machinery   Total
  £   £
At 01 June 2023 3,850    3,850 
Additions  
Disposals  
At 31 March 2024 3,850    3,850 
Depreciation
At 01 June 2023 2,069    2,069 
Charge for period 483    483 
On disposals  
At 31 March 2024 2,552    2,552 
Net book values
Closing balance as at 31 March 2024 1,298    1,298 
Opening balance as at 01 June 2023 1,781    1,781 


4.

Investments

Cost Other investments other than loans   Total
  £   £
At 01 June 2023 12,150    12,150 
Additions  
Transfer to/from tangible fixed assets  
Disposals  
At 31 March 2024 12,150    12,150 

5.

Creditors: amount falling due within one year

2024
£
  2023
£
Corporation Tax 11,455    14,344 
PAYE & Social Security 114    197 
Directors' Current Accounts  
11,574    14,541 

6.

Creditors: amount falling due after more than one year

2024
£
  2023
£
Other Creditors 60    34 
60    34 

7